The room on the screen shifted. Clare did not raise her voice, but every word carried the weight of a judge passing sentence.

Grant didn’t hear it over the pounding of blood in his ears. He was staring at the laptop screen, watching his entire empire—years of sleepless nights, FDA approvals, hostile takeovers, and media profiles in Forbes—evaporate like morning mist.

"Mr. Ashford?"

The voice came from the open doorway of his home office.

Grant spun around. Standing in the threshold was a tall, angular woman in a charcoal pantsuit. She held a leather briefcase in one hand and a tablet in the other. Behind her stood two uniformed security guards from the building’s concierge desk.

"How did you get in here?" Grant demanded, standing up so fast his leather chair crashed backward against the bookshelf. "Who authorized this?"

The woman didn't blink. She stepped into the room, her heels clicking sharply against the hardwood floor.

"My name is Sarah Lindqvist," she said calmly, pulling a laminated badge from her jacket pocket. "I am appointed as the court-supervised receiver for your personal and corporate assets under emergency seal by Judge Harrison of the New York Supreme Court. You are required by law to surrender all electronic devices, corporate keys, and security tokens immediately."

Grant let out a bitter laugh, stepping around the desk. "This is a domestic dispute. You can't bring a civil receivership into a residential apartment at six in the morning based on a disgruntled wife's—”

"It’s not a domestic dispute, Mr. Ashford," Lindqvist interrupted, her voice entirely devoid of emotion. "It’s a corporate fraud investigation. Mrs. Ashford didn't just walk out with a baby bag. She handed our forensic accounting team sixteen gigabytes of internal server logs proving you diverted three rounds of R&D capital from the Phase Three clinical trials into private shell accounts used to fund your personal lifestyle and third-party liabilities."

Grant froze.

The clinical trials. The Phase Three trials for Neura-G, their flagship Alzheimer’s treatment.

If those records were made public—if the FDA saw that capital had been siphoned off—the stock would hit zero before the opening bell at 9:30 AM. Criminal indictments would follow within forty-eight hours.

"Where is she?" Grant snarled, lunging forward before the security guards stepped cleanly into his path, their arms crossing like iron bars. "Where did she take my son?"

"Mrs. Ashford is currently under federal protective custody pursuant to an emergency domestic safety filing and a federal whistleblower protection rider," Lindqvist said, her eyes meeting his with cold indifference. "And as of four minutes ago, your corporate email account has been locked, your company car has been immobilized via GPS kill-switch, and your credit cards have been declined."